Galvus 50mg Tab
(28's pack: ৳ 882.00IndicationsVildagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus as monotherapy and in dual combination with Metformin, a Sulphonylurea, a Thiazolidinedione, or Insulin when diet, exercise and a single antidiabetic agent do not result in adequate glycemic control.PharmacologyVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones. Incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), are released by the intestine throughout the day, and levels are increased in response to a meal. These hormones are rapidly inactivated by the enzyme, DPP-4. The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. When blood glucose concentrations are normal or elevated, GLP-1 and GIP increase insulin synthesis and release from pancreatic beta cells by intracellular signaling pathways involving cyclic AMP. GLP-1 also lowers glucagon secretion from pancreatic alpha cells, leading to reduced hepatic glucose production. By increasing and prolonging active incretin levels, Vildagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner.IndicationsVildagliptin is indicated as an adjunct to diet and exercise to improve glycemic control in patients with type 2 diabetes mellitus as monotherapy and in dual combination with Metformin, a Sulphonylurea, a Thiazolidinedione, or Insulin when diet, exercise and a single antidiabetic agent do not result in adequate glycemic control.PharmacologyVildagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, which is believed to exert its actions in patients with type 2 diabetes by slowing the inactivation of incretin hormones. Incretin hormones, including glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), are released by the intestine throughout the day, and levels are increased in response to a meal. These hormones are rapidly inactivated by the enzyme, DPP-4. The incretins are part of an endogenous system involved in the physiologic regulation of glucose homeostasis. When blood glucose concentrations are normal or elevated, GLP-1 and GIP increase insulin synthesis and release from pancreatic beta cells by intracellular signaling pathways involving cyclic AMP. GLP-1 also lowers glucagon secretion from pancreatic alpha cells, leading to reduced hepatic glucose production. By increasing and prolonging active incretin levels, Vildagliptin increases insulin release and decreases glucagon levels in the circulation in a glucose-dependent manner...
Available for request
Ex Tax: Tk.882.00/=
Agrippal (Inj) 0.5ml
Price: 650 TK Generic:Octreotide acetate Type:Injection Quantity:1's pack Dose0.5ml..
Available for request
Ex Tax: Tk.650.00/=
Agrippal S1 0.5 ml/prefilled syringe IM/Deep SC Injection
Agrippal S1 0.5 ml/prefilled syringe IM/Deep SC Injection..
Available for request
Ex Tax: Tk.650.00/=
Co-diovan 80 /12.5 (Tab) 12.5mg
Price৳ 672 TK (per pata)NameCo-Diovan 80 /12.5GenericValsartanTypeTabletQuantity28's packPieces per pata14Dose12.5mg..
Available for request
Ex Tax: Tk.0.00/=
Cosentyx 150 mg/ml Injection
Cosentyx 150 mg/ml Injection,150 mg pre-filled pen..
Available for request
Ex Tax: Tk.63,001.64/=
Desferal 500 mg/vial Injection
Desferal 500 mg/vial Injection..
Available for request
Ex Tax: Tk.258.10/=
